Cargando…

Convalescent plasma donors show enhanced cross‐reactive neutralizing antibody response to antigenic variants of SARS‐CoV‐2 following immunization

BACKGROUND: The therapeutic benefit of convalescent plasma (CP) therapy to treat COVID‐19 may derive from neutralizing antibodies (nAbs) to SARS‐CoV‐2. To investigate the effects of antigenic variation on neutralization potency of CP, we compared nAb titers against prototype and recently emerging st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harvala, Heli, Nguyen, Dung, Simmonds, Peter, Lamikanra, Abigail A., Tsang, Hoi Pat, Otter, Ashley, Maes, Piet, Webster, Mhairi, Clarkson, Adam, Kaloyirou, Fotini, Hopkins, Valerie, Laidlaw, Stephen M., Carroll, Miles, Mora, Ana, Griffiths, Alexandra, MacLennan, Sheila, Estcourt, Lise, Roberts, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348319/ https://www.ncbi.nlm.nih.gov/pubmed/35588314 http://dx.doi.org/10.1111/trf.16934

Ejemplares similares

The Relationship Between SARS-CoV-2 Neutralizing Antibody Titers and Avidity in Plasma Collected From Convalescent Nonvaccinated and Vaccinated Blood Donors
por: Nurmi, Visa, et al.
Publicado: (2023)

Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Strain Variation on Virus Neutralization Titers: Therapeutic Use of Convalescent Plasma
por: Nguyen, Dung, et al.
Publicado: (2021)

Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
por: Shankar-Hari, Manu, et al.
Publicado: (2020)

Comparability of six different immunoassays measuring SARS‐CoV‐2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction
por: Lamikanra, Abigail, et al.
Publicado: (2021)

Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020
por: Harvala, Heli, et al.
Publicado: (2020)

Convalescent Plasma for Covid-19 — Making Sense of the Inconsistencies
por: Estcourt, Lise, et al.
Publicado: (2022)

The Prevention and Treatment of Some Obscure Conditions Complicating Convalescence after Gastro-Enterostomy
por: MacLennan, Alex.
Publicado: (1916)

Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England
por: Williams, Sarah, et al.
Publicado: (2022)

Evaluating the risk of transfusion and transplant‐transmitted monkeypox infections
por: Harvala, Heli, et al.
Publicado: (2022)

Comparison of SARS‐CoV‐2 neutralizing antibody testing of convalescent plasma donations in the Netherlands and England: A pilot study
por: Harvala, Heli, et al.
Publicado: (2021)

Understanding the outcomes of COVID-19 – does the current model of an acute respiratory infection really fit?
por: Simmonds, Peter, et al.
Publicado: (2020)

International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection
por: Murphy, Michael, et al.
Publicado: (2020)

Convalescent plasma therapy for persistent hepatitis E virus infection
por: Ankcorn, Michael, et al.
Publicado: (2019)

Convalescent plasma for COVID-19: male gender, older age and hospitalisation associated with high neutralising antibody levels, England, 22 April to 12 May 2020
por: Mehew, Jennifer, et al.
Publicado: (2020)

Increase in Enterovirus D68 Infections in Young Children, United Kingdom, 2006–2016
por: Kamau, Everlyn, et al.
Publicado: (2019)

Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006–2017
por: Kamau, Everlyn, et al.
Publicado: (2021)

How should we use convalescent plasma therapies for the management of COVID-19?
por: Wood, Erica M., et al.
Publicado: (2021)

Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 Infection
por: Ratcliff, Jeremy, et al.
Publicado: (2021)

Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial
por: Fish, M., et al.
Publicado: (2022)

Mapping of serological testing and SARS-CoV-2 seroprevalence studies performed in 20 European countries, March-June 2020
por: Bubba, Laura, et al.
Publicado: (2021)

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial
por: Desmarets, Maxime, et al.
Publicado: (2023)

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary
por: Wouters, Elise, et al.
Publicado: (2020)

The Migratory Properties and Numbers of T Regulatory Cell Subsets in Circulation Are Differentially Influenced by Season and Are Associated With Vitamin D Status
por: Lamikanra, Abigail A., et al.
Publicado: (2020)

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
por: Nguyen, Dung, et al.
Publicado: (2021)

Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial
por: McEniery, Carmel M., et al.
Publicado: (2020)

Genetic characterization of human coxsackievirus A6 variants associated with atypical hand, foot and mouth disease: a potential role of recombination in emergence and pathogenicity
por: Gaunt, Eleanor, et al.
Publicado: (2015)

ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial
por: McEniery, Carmel M., et al.
Publicado: (2020)

Changes in transmission of Enterovirus D68 (EV-D68) in England inferred from seroprevalence data
por: Pons-Salort, Margarita, et al.
Publicado: (2023)

T-Regulatory Cells and Inflammatory and Inhibitory Cytokines in Malawian Children Residing in an Area of High and an Area of Low Malaria Transmission During Acute Uncomplicated Malaria and in Convalescence
por: Nyirenda, Tonney S., et al.
Publicado: (2015)

Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels
por: Harvala, Heli, et al.
Publicado: (2020)

Process evaluation for the FEeding Support Team (FEST) randomised controlled feasibility trial of proactive and reactive telephone support for breastfeeding women living in disadvantaged areas
por: Hoddinott, Pat, et al.
Publicado: (2012)

Genetics, Recombination and Clinical Features of Human Rhinovirus Species C (HRV-C) Infections; Interactions of HRV-C with Other Respiratory Viruses
por: Wisdom, Anne, et al.
Publicado: (2009)

How Do We Meet the Supportive Care and Information Needs of Those Living With and Beyond Bladder Cancer?
por: MacLennan, Sara Jane, et al.
Publicado: (2020)

Enumerating regulatory T cells in cryopreserved umbilical cord blood samples using FOXP3 methylation specific quantitative PCR
por: Duggleby, Richard C., et al.
Publicado: (2020)

Fulminant Transfusion-Associated Hepatitis E Virus Infection Despite Screening, England, 2016–2020
por: Harvala, Heli, et al.
Publicado: (2022)

Distinct gene expression program dynamics during erythropoiesis from human induced pluripotent stem cells compared with adult and cord blood progenitors
por: Merryweather-Clarke, Alison T., et al.
Publicado: (2016)

On the Management and Treatment of Hæmoptysis
por: MacLennan, William
Publicado: (1908)

Notes on a Case of Post-Operative Pulmonary Embolism, Simulating Pneumonia
por: MacLennan, Alex.
Publicado: (1900)

Simple Peptic Ulcer and Malignant Disease of the Stomach
por: MacLennan, William
Publicado: (1915)

Types of Bullet Wounds Observed in No. 3 Scottish General Hospital, Stobhill
por: MacLennan, Alex.
Publicado: (1915)

Cannot write session to /tmp/vufind_sessions/sess_ip8ht6ovdco5hff5s5fs0fnsf6